Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Feb;12(2):76-80.
doi: 10.13107/jocr.2022.v12.i02.2674.

Approach to Total Hip Arthroplasty in Gauchers Disease with Pre-Existing Spinopelvic Fusion

Affiliations
Case Reports

Approach to Total Hip Arthroplasty in Gauchers Disease with Pre-Existing Spinopelvic Fusion

D J Vinay et al. J Orthop Case Rep. 2022 Feb.

Abstract

Introduction: Avascular necrosis of femoral head secondary to rare metabolic Gaucher's disease (GD) can cause debilitating hip arthritis in young adults. It is an autosomal recessive disorder caused due to deficiency of lysosome enzyme glucocerebrosidase resulting in accumulation of its substrate in macrophages. The activated macrophages or the Gaucher cells causes hepatosplenomegaly, anemia, and thrombocytopenia. Extensive marrow involvement causes bony deformity, necrosis, and pathological fractures in non-neuropathic GD. Total hip replacement (THR) for young adult with secondary arthritis due to avascular necrosis (AVN) of femoral head in GD is complex and has high failure rate. As the abnormal cell infiltration involves both femoral head and the acetabulum. It becomes even more challenging, when associated spinopelvic fusion preexists. The altered biomechanics needs special attention to the anteversion of the cup placement and deciding the combined ante-version angle (CAVA).

Case presentation: We report a case of GD with avascular necrosis of the femoral head, who underwent spinopelvic fusion to address his osteonecrosis of lumbar vertebra. Previously unreported, here we will discuss the pre-operative radiological evaluation and other intra-operative challenges in the management of GD post-enzyme replacement therapy (ERT) with secondary hip arthritis by THR.

Conclusion: Hip replacement surgery in patients with Gaucher disease related to secondary arthritis restores pain free mobility. Despite the young age of the patients with GD, prognosis remains better with THR after enzyme replacement therapy. The pre-operative planning, anticipation of complications in metabolically abnormal hip joints makes it a complex primary THR. However, in patients with the spinopelvic fusion placement of the cup, at the narrow range of angle of version with altered spinopelvic rhythm plays an important role in post-operative prosthetic hip stability and patient mobility.

Keywords: Gaucher’s disease; enzyme replacement therapy; spinopelvic fusion; total hip arthroplasty.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: Nil

Figures

Figure 1
Figure 1
X-ray lumbo-sacral spine AP and lateral view showing l5 vertebra plana with spinopelvic fusion.
Figure 2
Figure 2
(a) (Left) Pre-operative clinical picture showing loss of lumbar lordosis. (b) (Right): Pre-operative X-ray pelvis with bilateral hips showing right deformed head of femur.
Figure 3
Figure 3
(Above and below): One year pre-operative follow-up showing the progression of deformed femoral head.
Figure 4
Figure 4
Pre-operative planning and calculation of acetabular ante-version, pelvic tilt and sacral slope in standing and sitting posture for intra-operative acetabular cup placement.
Figure 5
Figure 5
Immediate post-operative X-ray taken.
Figure 6
Figure 6
Six months (a) and 1 year (b) post-operative follow-up X-ray.

Similar articles

References

    1. Charrow J, Andersson HC, Kaplan P, Kolodny EH, Mistry P, Pastores G, et al. Enzyme replacement therapy and monitoring for children with type I Gaucher disease:Consensus recommendations. J Pediatr. 2004;144:112–20. - PubMed
    1. Hughes D, Mikosch P, Belmatoug N, Carubbi F, Cox T, Goker-Alpan O, et al. Gaucher disease in bone:From pathophysiology to practice. J Bone Miner Res. 2019;34:996–1013. - PMC - PubMed
    1. Stowens DW, Teitelbaum SL, Kahn AJ, Barranger JA. Skeletal complications of Gaucher disease. Medicine (Baltimore) 1985;64:310–22. - PubMed
    1. Lineri S, Castaman G. Clinical manifestation and management of Gauchers disease. Clin Cases Min Bone Metab. 2015;12:157–64. - PMC - PubMed
    1. Bubbar V, Heras FL, Amato D, Pritzker KP, Gross AE. Total hip replacement in Gaucher's disease:Effects of enzyme replacement therapy. J Bone Joint Surg Br. 2009;91:1623–7. - PubMed

Publication types

LinkOut - more resources